Dipyridamole-associated headache in stroke patients- Interindividual differences?

European Neurology

Volumn 62, Issue 2, 2009, Pages 109-113

  Lokk J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dipyridamole; Headache; Ischemic stroke; Titration; Transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; PARACETAMOL;

ADULT; AGE DETERMINATION; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SEX DIFFERENCE; STROKE UNIT; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASPIRIN; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; FEMALE; HEADACHE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PILOT PROJECTS; RISK FACTORS; SECONDARY PREVENTION; SEX FACTORS; STROKE; TIME FACTORS; VASODILATOR AGENTS;

EID: 66749130224     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000222782     Document Type: Article

References (17)

1. Leonardo-Bee J, Bath PM, Bousser MG, Davalos A, Diener HC, Guiraud-Chaumeil B, et al: Dipyridamole for preventing recurrent ischemic stroke and other vascular events. A meta-analysis of individual patient data from randomized controlled trials. Stroke 2005; 36:162-168.
2. Leoo T, Lindgren A, Petersson J, von Arbin M: Risk factors and treatment at recurrent stroke onset: results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study. Cerebrovasc Dis 2008; 25: 254-260.
3. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A: European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 14 3 : 1-13.
4. ESPRIT Study Group; Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A: Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367: 1665 -1673.
5. Sacco RL, Diener HC, Yusuf S, Phil BS, Cotton D, Öunpuu S: Aspirin and extended release dipyridamole versus clopidogrel for recurrent stroke. N Eng l J Med 2008; 359: 1-14.
6. Kruuse C, Jacobsen TB, Lassen LH, Thomsen LL, Hasselbach SG, Dige-Petersen H, et al: Dipyridamole dilates large cerebral arteries concomitant to headache induction in healthy subjects. J Cereb Blood Flow Metab 2000; 20:1372-1379.
7. Kruuse C, Lassen LH, Iversen HK, Oestergaard S, Olesen J: Dipyridamole may induce migraine in patients with migraine without aura. Cephalalgia 2006; 26: 925-933.
8. Chang YJ, Ryu SJ, Lee TH: Dose titration to reduce dipyridamole-related headache. Cerebrovasc Dis 2006; 22:258-262.
9. Lökk J, Tänglander M: Successive administration of a common secondary stroke prevention causes fewer side effects. Vardi Norden 2003; 23:21-23.
10. Lindgren A, Husted S, Staaf G, Ziegler B: Dipyridamole and headache - a pilot study of initial dose titration. Neurol Sci 2004; 223: 179 -18 4 .
11. Karlikaya G, Varlbas F, Demirkaya M, Orken C, Tireli H: Does prior aspirin use reduce stroke mortality? Neurologist 2006; 12:263- 267.
12. Lipton RB, Bigal ME, Kolodner KB, Gorelick PB, Wilks K, Scoebelock M, et al: Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination. Neurology 2004; 63:1099-1101.
13. Theis JG, Diechsel G, Marshall S: Rapid development of tolerance to dipyridamole-as-sociated headaches. Br J Clin Pharmacol 1999; 48: 750 -755.
14. Headache Classification Subcommittee of the International Headache Society: The international classification of headache disorders, ed 2. Cephalalgia 2004; 24(suppl 1):1-160.
15. Bult H, Fret HR, Jordaens FH, Herman AG: Dipyridamole potentiates platelet inhibition by nitric oxide. Thromb Haemost 1991; 66: 343-349.
16. Schaper W: Dipyridamole, an underestimated vascular protective drug. Cardiovasc Drugs Ther 2005; 19 : 357-363.
17. Weinberger J: Adverse effects and drug interactions of antithrombotic agents used in prevention of ischemic stroke. Drugs 2005; 65: 461-471.